IE49754B1 - A vaccine for combating pleuropneumonia in pigs and a process and a substrate for the aerobic fermentation of haemophilus pleuropneumoniae - Google Patents

A vaccine for combating pleuropneumonia in pigs and a process and a substrate for the aerobic fermentation of haemophilus pleuropneumoniae

Info

Publication number
IE49754B1
IE49754B1 IE69680A IE69680A IE49754B1 IE 49754 B1 IE49754 B1 IE 49754B1 IE 69680 A IE69680 A IE 69680A IE 69680 A IE69680 A IE 69680A IE 49754 B1 IE49754 B1 IE 49754B1
Authority
IE
Ireland
Prior art keywords
vaccine
pleuropneumoniae
substrate
fermentation
pigs
Prior art date
Application number
IE69680A
Other languages
English (en)
Other versions
IE800696L (en
Original Assignee
Nordisk Droge & Kemikalie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Droge & Kemikalie filed Critical Nordisk Droge & Kemikalie
Publication of IE800696L publication Critical patent/IE800696L/xx
Publication of IE49754B1 publication Critical patent/IE49754B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IE69680A 1979-04-04 1980-04-03 A vaccine for combating pleuropneumonia in pigs and a process and a substrate for the aerobic fermentation of haemophilus pleuropneumoniae IE49754B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK138379A DK138379A (da) 1979-04-04 1979-04-04 Vaccine imod pleuropneumonia (ondartet lungesyge) hos svin dens anvendelse samt fremgangsmaade og substat til dyrkning specielt aerob fermentering af mikroorganismen haemophilus pleuropneumoniae

Publications (2)

Publication Number Publication Date
IE800696L IE800696L (en) 1980-10-04
IE49754B1 true IE49754B1 (en) 1985-12-11

Family

ID=8104263

Family Applications (1)

Application Number Title Priority Date Filing Date
IE69680A IE49754B1 (en) 1979-04-04 1980-04-03 A vaccine for combating pleuropneumonia in pigs and a process and a substrate for the aerobic fermentation of haemophilus pleuropneumoniae

Country Status (10)

Country Link
EP (1) EP0026209A1 (fr)
JP (1) JPS56500339A (fr)
AT (1) ATA903480A (fr)
BE (1) BE882619A (fr)
DK (1) DK138379A (fr)
GB (1) GB2057882B (fr)
IE (1) IE49754B1 (fr)
NL (1) NL8020132A (fr)
SE (1) SE8008500L (fr)
WO (1) WO1980002113A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE66690B1 (en) * 1986-05-23 1996-01-24 Oread Pharmaceutical Inc Co-vaccination using non-O-carbohydrate side-chain gram-negative bacteria preparation
NL8802007A (nl) * 1988-08-12 1990-03-01 Centraal Diergeneeskundig Inst Vaccin, geschikt voor de profylaxe respectievelijk de bestrijding van de door haemophilus pleuropneumoniae teweeggebrachte ziekte bij varkens alsmede werkwijze voor het winnen van extracellulair eiwitachtig materiaal van haemophilus pleuropneumonie, geschikt voor toepassing in dergelijke vaccins.
FR2652266B1 (fr) * 1989-09-26 1994-08-12 Rhone Merieux Vaccin protecteur contre l'hemophilose porcine.
DE69110082T2 (de) * 1990-04-20 1995-11-09 Akzo Nobel Nv Untereinheit-Impfstoff gegen Actinobacillus Pleuropneumoniae.
US5925354A (en) * 1995-11-30 1999-07-20 Michigan State University Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae
AU2009100018B4 (en) * 2008-10-15 2009-09-03 Australasian Pork Research Institute Ltd A Method of vaccination

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2374042A1 (fr) * 1976-06-04 1978-07-13 Merieux Inst Nouveau medicament immunostimulant et son procede de preparation
JPS6019733B2 (ja) * 1977-06-10 1985-05-17 科研製薬株式会社 蛋白質性活性物質

Also Published As

Publication number Publication date
GB2057882B (en) 1983-05-18
GB2057882A (en) 1981-04-08
ATA903480A (de) 1984-05-15
BE882619A (fr) 1980-10-03
DK138379A (da) 1980-10-05
IE800696L (en) 1980-10-04
NL8020132A (nl) 1981-01-30
SE8008500L (sv) 1980-12-03
WO1980002113A1 (fr) 1980-10-16
EP0026209A1 (fr) 1981-04-08
JPS56500339A (fr) 1981-03-19

Similar Documents

Publication Publication Date Title
Blake et al. Studies on experimental pneumonia: I. Production of pneumococcus lobar pneumonia in monkeys
Felix A new type of typhoid and paratyphoid vaccine
AU8492391A (en) Inactivated mycoplasma hyopneumoniae bacterin and method of use thereof
CA1117416A (fr) Vaccin contre le cholera aviaire
US5378615A (en) Process for the production of vaccine for prevention of Pasteurella haemolytica pneumonia in bovine
CN113957007A (zh) 一种鸡滑液囊支原体灭活疫苗
IE49754B1 (en) A vaccine for combating pleuropneumonia in pigs and a process and a substrate for the aerobic fermentation of haemophilus pleuropneumoniae
Freundt Experimental investigations into the pathogenicity of the L‐phase variant of Streptobacillus moniliformis
Rimler et al. A growth medium for the production of a bacterin for immunization against infectious coryza
US4472378A (en) Live vaccine for the prevention of salmonellosis in water fowl, a process for making and applying the same
EP0625190A1 (fr) Nouvelle bacterie provoquant des maladies chez les volailles et vaccin derive de cette bacterie.
Littman et al. Treatment of pulmonary actinomycosis with chloramphenicol: report of a case
CA1189790A (fr) Procede et substrat pour la fermentation aerobie d'haemophilus pleuropneumoniae
US4350684A (en) Preparation of Salmonella abortus ovis strains and vaccine compositions containing them
CA1336956C (fr) Vaccin de type pasteurella multocida
CN110124022A (zh) 一种猪肺炎支原体与副猪嗜血杆菌、猪链球菌、胸膜肺炎放线杆菌四联灭活疫苗及其应用
Elias et al. Clinical and pathological effects of the dermonecrotic toxin of Bordetella bronchiseptica and Pasteurella multocida in specific-pathogen-free piglets.
KR101210082B1 (ko) 돼지 다발성 장막염 예방용 백신 조성물 및 그 제조방법
KR101209964B1 (ko) 돼지 다발성 장막염 예방용 백신 조성물 및 그 제조방법
JPH0825898B2 (ja) エシェリキア、コリによって起こされる尿道感染に対する免疫化用組成物
Gugnani et al. Mycetoma of thumb caused by Nocardia transvalensis
US4002736A (en) Porcine bacterin
SE431400B (sv) Lactobacterium acidophilum-heterovaccin for terapeutisk behandling av trikomonasinfektion
US4379140A (en) Turkey rhinotracheitis vaccine
US3843451A (en) Microorganism production